Tirzepatide vs Liraglutide
Which has more real evidence behind it? This compares how well each has been tested, not which one works better.
This page has not yet been reviewed by a credentialed medical professional. It is educational and is not medical advice.
Both are at the same evidence level (FDA-approved), but Liraglutide has more randomized trials on PubMed (561 vs 133). Both are approved medicines; the right choice depends on your situation and a clinician.
The research, side by side
Counts come from PubMed and ClinicalTrials.gov searches and can include studies that only mention a peptide. Bars use a log scale.
| Tirzepatide | Liraglutide | |
|---|---|---|
| What people use it for | Weight loss and type 2 diabetes. Dual GIP/GLP-1 agonist. | Weight loss (Saxenda) and type 2 diabetes (Victoza). A daily GLP-1 drug that came before semaglutide. |
| Approved as a medicine | Type 2 diabetes and chronic weight management; sleep apnea | Type 2 diabetes; chronic weight management |
| What the evidence says | Approved for type 2 diabetes and chronic weight management, with large randomized trials and a head-to-head against semaglutide. | Approved, with large randomized trials. Semaglutide beat it head-to-head for weight loss. |
| In tested sport | Not prohibited | Not prohibited |
Common questions
Which is better, Tirzepatide or Liraglutide?
No study compares them head to head for most uses, so this page compares how much evidence exists, not which works better. Both are at the same evidence level (FDA-approved), but Liraglutide has more randomized trials on PubMed (561 vs 133).
Is Tirzepatide or Liraglutide approved?
Tirzepatide: Type 2 diabetes and chronic weight management; sleep apnea. Liraglutide: Type 2 diabetes; chronic weight management.
Can you take Tirzepatide and Liraglutide together?
We found no controlled studies testing Tirzepatide and Liraglutide together, so the effects and safety of combining them are unknown. Talk to a clinician.
Keep exploring
Educational only, not medical advice. "What people use it for" describes common claims, not recommendations.